Keyphrases
Acute Myeloid Leukemia
100%
Myelodysplastic Syndrome
100%
Objective Response
100%
Azacitidine
100%
Decitabine
100%
Hypomethylating Agents
33%
Azacitidine Failure
33%
Cancer Center
16%
Disease Progression
16%
Median Survival
16%
Stable Disease
16%
Treatment Failure
16%
Cytotoxic Chemotherapy
16%
Complete Remission
16%
2-cycles
16%
University of Maryland
16%
Partial Remission
16%
Disease Stabilization
16%
Hematologic Improvement
16%
2-median
16%
Myelodysplastic Syndrome/myeloproliferative Neoplasm
16%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Myelodysplastic Syndrome
100%
Azacitidine
100%
Decitabine
100%
Diseases
33%
Hypomethylating Agent
33%
Disease Exacerbation
16%
Cytotoxic Chemotherapy
16%
Malignant Neoplasm
16%
Myeloproliferative Neoplasm
16%
Pharmacology, Toxicology and Pharmaceutical Science
Azacitidine
100%
Acute Myeloid Leukemia
100%
Myelodysplastic Syndrome
100%
Decitabine
100%
Disease
33%
Cytotoxic Chemotherapy
16%
Myeloproliferative Neoplasm
16%
Malignant Neoplasm
16%
Disease Exacerbation
16%
Remission
16%